Monitoring intravesical therapy for superficial bladder cancer using fluorescence in situ hybridization

Journal of Urology

Volumn 173, Issue 2, 2005, Pages 401-404

  Kipp, Benjamin R ^a   Karnes, R Jeffrey ^b   Brankley, Shannon M ^a   Harwood, Aaron R ^a   Pankratz, V Shane ^a   Sebo, Thomas J ^a   Blute, Michael M ^b   Lieber, Michael M ^b   Zincke, Horst ^b   Halling, Kevin C ^a  

^a MAYO CLINIC   (United States)

^b DEPARTMENT OF UROLOGY   (United States)

Author keywords

Bladder; Bladder neoplasms; Fluorescence; In situ hybridization; Mycobacterium bovis; Outcome and process assessment

Indexed keywords

BCG VACCINE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GROWTH; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MONITORING; DRUG RESPONSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; MALE; PRIORITY JOURNAL; TUMOR RECURRENCE;

EID: 19944433978     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000149825.83180.a4     Document Type: Article

References (20)

1. Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E. and Thin, M.: Cancer statistics, 2003. CA Cancer J Clin, 53: 5, 2003
2. Donat, S. M.: Evaluation and follow-up strategies for superficial bladder cancer. Urol Clin North Am, 30: 765, 2003
3. Lee, R. and Droller, M. J.: The natural history of bladder cancer. Implications for therapy. Urol Clin North Am, 27: 1, 2000
4. Dalbagni, G. and Herr, H.: Current use and questions concerning intravesical bladder cancer group for superficial bladder cancer. Urol Clin North Am, 27: 137, 2000
5. Reuter, V. E. and Melamed, M. R.: The lower urinary tract. In: Diagnostic Surgical Pathology. Edited by S. S. Sternberg. New York: Raven Press, chapt. 13, pp. 1767-1805, 1994
6. Soloway, M. S.: Overview of treatment of superficial bladder cancer. Urology, suppl., 26: 18, 1985
7. Cookson, M. S., Herr, H. W., Zhang, Z.-F., Soloway, S., Sogani, P. C. and Fair, W. R.: The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol, 158: 62, 1997
8. Sokolova, I. A., Halling, K. C., Jenkins, R. B., Burkhardt, H. M., Meyer, R. G., Seelig, S. A. et al: The development of multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. J Mol Diagn, 2: 116, 2000
9. Sarosdy, M. F., Schellhammer, P., Bokinsky, G., Kahn, P., Chao, R., Yore, L. et al: Clinical evaluation of multi-target fluorescent in situ hybridization assay for the detection of bladder cancer. J Urol, 168: 1950, 2002
10. Mian, C., Lodde, M., Comploj, E., Negri, G., Egarter-Vigl, E., Lusuardi, L. et al: Liquid-based cytology as a tool for the performance of uCyl+ and Urovysion Multicolour-FISH in the detection of urothelial carcinoma. Cytopathology, 14: 338, 2003
11. Skacel, M., Fahmy, M., Brainard, J. A., Pettay, J. D., Biscotti, C. V., Liou, L. S. et al: Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. J Urol, 169: 2101, 2003
12. Halling, K. C., King, W., Sokolova, I. A., Karnes, R. J., Meyer, R. G., Powell, E. L. et al: A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine. J Urol, 167: 2001, 2002
13. Bubendorf, L., Grilli, B., Sauter, G., Mihatsch, M. J., Gasser, T. C. and Dalquen, P.: Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings. Am J Clin Pathol, 116: 79, 2001
14. Veeramachaneni, R., Nordberg, M. L., Shi, R., Herrera, G. A. and Turbat-Herrera, E. A.: Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma. Diagn Cytopathol, 28: 301, 2003
15. Halling, K. C., King, W., Sokolova, I. A., Meyer, R. G., Burkhardt, H. M., Halling, A. C. et al: A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol, 164: 1768, 2000
16. Joudi, F. N., Smith, B. J., O'Donnell, M. A. and Konety, B. R.: Contemporary management of superficial bladder cancer in the United States: a pattern of care analysis. Urology, 62: 1083, 2003
17. Smith, J. A., Jr., Labasky, R. F., Cockett, A. T. K., Fracchia, J. A., Montie, J. E. and Rowland, R. G.: Bladder Cancer Clinical Guidelines Panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and TIS). J Urol, 162: 1697, 1999
18. Bardales, R. H.: Practical Urologic Cytopathology. New York: Oxford University Press, 2002
19. Kriegmair, M., Baumgartner, R., Knuechel, R., Steinbach, P., Ehsan, A., Lumper, W. et al: Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5 aminolevulinic acid. Urology, 44: 836, 1994
20. Mack, D. and Frick, J.: Diagnostic problems of urine cytology on initial follow-up after intravesical immunotherapy with Calmette-Guerin bacillus for superficial bladder cancer. Urol Int, 52: 204, 1994